Mair Therapeutics
PrivateLast Round
Pre Seed
Feb 13, 2025
Company Overview
Mair Therapeutics operates in Healthcare & Life Sciences and is based in Nijmegen. Its latest recorded funding round was a Pre Seed round in February 2025.
Mair Therapeutics is a biotechnology company that develops therapies for neurodegenerative diseases, with a primary focus on Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mair Therapeutics Comparables
Compare Mair Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeurOdys Therapeutics | 89% | |
| Lysoway Therapeutics | 82% | |
| Casma Therapeutics | 77% |
For institutional investors. Book with your work email.
Mair Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Mair Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Expert Systems Inc. | Pre Seed |
| Torrey Pines Investment LLC | Pre Seed |
| Oost NL | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 13, 2025
Secured Pre Seed funding from Torrey Pines Investment, Expert Systems, and Oost NL.
For institutional investors. Book with your work email.
Mair Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mair Therapeutics's valuation, stock price, and market status.
Is Mair Therapeutics a public or private company?
Mair Therapeutics is a private company.
What is the current stock price of Mair Therapeutics?
Mair Therapeutics is a private company, so its shares have no public market price. Caplight tracks Mair Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mair Therapeutics worth (valuation)?
Valuation information for Mair Therapeutics is not publicly available.
Can I buy Mair Therapeutics stock?
Mair Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mair Therapeutics's last funding round?
Mair Therapeutics's most recent funding round was Pre Seed on February 13, 2025.
Who are the main investors in Mair Therapeutics?
Key investors in Mair Therapeutics include Expert Systems Inc., Torrey Pines Investment LLC, Oost NL.
Will Mair Therapeutics IPO soon?
No public IPO plans have been announced for Mair Therapeutics.
How can I track Mair Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Mair Therapeutics's shares on secondary markets.